Chapter 27 Health Promotion, Disease Prevention, and Population Health(ASCVD)

Question 1

a U.S. Department of Health and Human Services

initiative

Answer 1

Healthy people 2020

Question 2

four overarching areas in health as goals

Answer 2

High quality
Protect health in all stages
xHealth disparities
Promote health

PROTECT/PROMOTE

Question 3

most common cause of death of Americans

Answer 3

Atherosclerotic disease

Question 4

Four main Atherosclerotic diseases

Answer 4

CHD
CVD
Cerebrovascular disease
PAD
Aortic atherosclerosis/thoracic/abdominal aortic aneurysm

Question 5

ASCVD risk assessment should begin at age _______

Answer 5

20 y/o

Question 6

How often do low-risk patients reassess for ASCVD risk

Answer 6

4-6 yrs

ASCVD low risk for(4-6)~~~

Question 7

How often do higher risk patients reasses for ASCVD

Answer 7

q 2yrs

Question 8

ASCVD risk assessment is not recommended after age _____

Answer 8

79 y

Question 9

ASCVD risk calculator identifies what

Answer 9

(primary prevention)
10 yr risk for those who have not developed
atherosclerotic cardiovascular disease (ASCVD) to date

Question 10

ASCVD Modifiable risks

Answer 10

Hypertension
Hyperlipidemia
Diabetes
Smoking

Question 11

ASCVD Non-Modifiable risks:AGE

Answer 11

> 45 in men > 55 in women

4555 age

Question 12

ASCVD Non-Modifiable risks:GENDER

Answer 12

Males at greater risk til women’s 60 y/o

Question 13

ASCVD Non-Modifiable risks:Ethnicity

Answer 13

African Americans

Question 14

ASCVD Non-Modifiable risks:Family history

Answer 14

55 years of age or female primary relative less than 65 years of age

Question 15

2 or more traditional risk factors or greater than 40

Answer 15

10 yr risk calculation

Question 16

For patients with low to very low 10 yr risk

Answer 16

lifetime risk can be estimated

Question 17

preferred by the American

College of Cardiology (ACC)/American Heart Association (AHA).

Answer 17

ASCVD Pooled Cohort Equation (2013)

Question 18

predicts cardiovascular and

cerebrovascular events as well as softer endpoints such as heart failure.

Answer 18

Framingham (2008 global version)

FRAMINGSOFTHEART

Question 19

includes

multiple ethnic backgrounds.

Answer 19

MESA (Multi-Ethnic Study of Atherosclerosis)

Question 20

includes hsCRP (high-sensitivity C-reactive
protein).

Answer 20

Reynolds Risk Score (2008)

RR is A CReeP

Question 21

is regarded as high enough risk

to benefit from statin therapy

Answer 21

7.5%

Question 22

may warrant aspirin therapy for primary prevention of atherosclerotic
disease

Answer 22

10%

Question 23

Statin therapy for patient >____ LDL-C level

Answer 23

> 190 mg/dL LDL-C

190!!!!!!

Question 24

Statin therapy for patient age 40–79 years with diabetes and LDL-C greater than ____

Answer 24

70mg/dL

40-79 70

Question 25

Statin therapy for patient age 40–79 years without diabetes and LDL-C greater than ____ and a 10 yr ASCVD risk of greater than ___

Answer 25

70,7.5%

70/7.5

Question 26

High intensity statin

Answer 26

Ator4t0-80-

Rosu-20-40

Question 27

HMGCoARi intensities

Answer 27

50%
30%
<30%

Question 28

for men and women 50-70 years who have a 10 yr risk of greater than 10% the US preventive Services Task Force recommends

Answer 28

Aspirin

Question 29

Aspirin is not currently recommended for patients over ____y/o because of the lack of evidence of clear benefit in this population.

Answer 29

80

Question 30

Do not use aspirin in patients with an increased risk of _____ and _____

Answer 30

gastrointestinal
bleed or hemorrhagic stroke.
GIB HS

Question 31

is aspirin recommended for people below 50?

Answer 31

No, bleeding risk is higher than perceived risks of ascvd prevention

Question 32

Aspirin reduces risk of ____ in women until age 65 where they have equal risks compared to men

Answer 32

Stroke

Question 33

Aspirin reduces risk of ____ in men until age 65 where they have equal risks compared to women

Answer 33

MI